combination chemotherapy

Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to combination chemotherapy: antitumor, Chemotherapeutic agent

combination chemotherapy

chemotherapy using more than a single drug to exploit the varying levels of toxicity for the patient's benefit.

combination chemotherapy

the simultaneous use of two or more anticancer drugs.

com·bi·na·tion che·mo·ther·a·py

(kom-bi-nāshŭn kē-mō-thāră-pē)
Therapy using more than a single drug to exploit the varying levels of toxicity for the patient's benefit.


the treatment of illness by chemical means; that is, by medication.

cancer chemotherapy
the use of antineoplastic agents in the treatment of malignant growths; usually employed because treatment by other means, such as surgical removal, is not possible. A variety of malignancies in dogs and cats have been successfully managed with some of the chemotherapeutic agents used in the treatment of cancer in humans.
combination chemotherapy
several drugs are used in parallel or in sequence. A common procedure in human cancer therapy.
multimodal chemotherapy
chemotherapy combined with other forms of treatment, e.g. surgical excision.
References in periodicals archive ?
3%), and the incidence of grade III-IV severity of these adverse reactions in the combination chemotherapy were 7.
FUSILEV is indicated for use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer.
A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer.
The advantages of using cell encapsulation with combination chemotherapy regimens are of great interest to us.
In conclusion, results from the Phase II trial and the combined analysis confirm that 5-FU/irinotecan combination chemotherapy is an acceptable first-line treatment strategy in metastatic colorectal cancer for the elderly with good performance status.
This Phase II trial will study the effectiveness of combination chemotherapy and peripheral stem cell transplantation in treating patients who have undergone surgery for stage III ovarian cancer.
Food and Drug Administration approved ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in January 2005 for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within six months of adjuvant chemotherapy.
Combination chemotherapy with or without the use of new antibodies is considered an important treatment option for patients with metastatic disease.
Combination chemotherapy with cisplatin and paclitaxel has been adopted widely as the standard of care because of its efficacy, but this regimen has been plagued by toxicity, Dr.
L-asparaginase is a critical and irreplaceable component of combination chemotherapy for ALL and has been used in the clinic for over 30 years.
In addition, the study showed that 25% of patients might be best treated with a single agent selected by the MiCK assay rather than a more expensive and more toxic combination chemotherapy regimen.
Combination chemotherapy including infusional 5-fluorouracil (5FU)/leucovorin with irinotecan (FOLFIRI) or with oxaliplatin (FOLFOX) is considered a reference first-line chemotherapy.